comparemela.com

Page 7 - Takeda Pharmaceuticals International News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data from Across Incyte s Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress

Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual

Anti-nausea drug gets in cells to offer lasting pain relief

HUTCHMED (China) Limited: HUTCHMED Reports 2022 Full Year Results and Provides Business Updates

Landmark licensing deal with Takeda for fruquintinib outside of China, bringing HUTCHMED up to US$1.13 billion, plus royalties, and demonstrating execution of the new global strategy Record Full Year

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.